FDA Inspection 1227745 — Herman Ayvazyan, M.D.

Herman Ayvazyan, M.D. — FEI 3029741307

The FDA completed an inspection of Herman Ayvazyan, M.D. on Jan 25, 2024 in East Providence, RI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 25, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
East Providence, RI (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.